BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22138425)

  • 1. Modern device technologies.
    Crozier I; Smith W
    Heart Lung Circ; 2012 Jun; 21(6-7):320-7. PubMed ID: 22138425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Arrhythmias in Adults with Congenital Heart Disease: Pacemakers, Implantable Cardiac Defibrillators, and Cardiac Resynchronization Therapy Devices.
    Cecchin F; Halpern DG
    Card Electrophysiol Clin; 2017 Jun; 9(2):319-328. PubMed ID: 28457245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pacemaker, cardiac resynchonisation, implantable cardioverter/defibrillator, event monitoring].
    Klein N; Klein M; Pfeiffer D
    Dtsch Med Wochenschr; 2013 Dec; 138(49):2526-9. PubMed ID: 24281961
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electromagnetic interference : Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter-defibrillator].
    Nowak B; Przibille O; Napp A
    Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):297-304. PubMed ID: 35781834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
    Abraham WT
    Europace; 2013 Jun; 15 Suppl 1():i40-i46. PubMed ID: 23737229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Technologies in Electrophysiology: From Single-Chamber to Biventricular Leadless Pacemakers.
    Gill J
    Cardiology; 2022; 147(2):179-190. PubMed ID: 35038698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.
    Atreya AR; Cook JR; Lindenauer PK
    Postgrad Med; 2016; 128(2):223-30. PubMed ID: 26849147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latest results of treatment with pacemaker and implantable cardioverter defibrillators].
    Merkely B
    Orv Hetil; 2005 May; 146(20 Suppl 2):1088-98. PubMed ID: 15945237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint.
    Boriani G; Diemberger I; Biffi M; Martignani C; Ziacchi M; Bertini M; Valzania C; Bronzetti G; Rapezzi C; Branzi A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):422-33. PubMed ID: 17367364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on cardiac implantable electronic devices for the general physician.
    Peal JE; Mathews IG; Runnett C; Thomas HE; Ripley DP
    J R Coll Physicians Edinb; 2018 Jun; 48(2):141-147. PubMed ID: 29992205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia.
    Rozner MA
    Curr Opin Anaesthesiol; 2007 Jun; 20(3):261-8. PubMed ID: 17479032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
    Dubner S; Auricchio A; Steinberg JS; Vardas P; Stone P; Brugada J; Piotrowicz R; Hayes DL; Kirchhof P; Breithardt G; Zareba W; Schuger C; Aktas MK; Chudzik M; Mittal S; Varma N
    Europace; 2012 Feb; 14(2):278-93. PubMed ID: 22232544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart failure : current status of device therapy].
    Bergmann MW; Kuck KH
    Herz; 2011 Oct; 36(7):575-6. PubMed ID: 21987097
    [No Abstract]   [Full Text] [Related]  

  • 19. Electromagnetic interference between external defibrillator and cardiac resynchronization therapy-pacemaker (CRT-P) devices.
    Ghanbari H; Al-Ameri H; Ottino J; Hastings C; Kippola J; Gueron I; Daccarett M; Machado C
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1087-91. PubMed ID: 21605137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.